×
About 8,503 results

ALLMedicine™ Hepatitis B Virus Center

Research & Reviews  3,136 results

The Evaluation of Hepatitis B Screening and Reactivation in Patients Receiving Rituxima...
https://doi.org/10.1111/ijcp.14685
International Journal of Clinical Practice; Bozkurt I, Ozturk Cerik H et. al.

Aug 1st, 2021 - Hepatitis B virus (HBV) infection is a worldwide distributing viral disease. Hepatitis due to HBV reactivation may progress to chronic illness and associated with increased risk of hepatic failure and hepatocellular cancer. Rituximab (RTX) is an i...

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS B VIRUS.
https://doi.org/10.1016/j.clinre.2021.101773
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.

Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...

Risk of mother-to-child transmission of hepatitis B virus after fetal blood sampling: a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325253
BMC Infectious Diseases; Han Z, Zhang Y et. al.

Aug 1st, 2021 - Hepatitis B virus (HBV) remains a major global public health problem worldwide; in endemic areas, mother-to-child transmission (MTCT) of HBV is the most common transmission route. Previous studies have shown that amniocentesis for prenatal diagnos...

The trend of direct medical costs and associated factors in patients with chronic hepat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323196
BMC Medical Informatics and Decision Making; Yang S, Chen G et. al.

Aug 1st, 2021 - Although the expenses of liver cirrhosis are covered by a critical illness fund under the current health insurance program in China, the medical costs associated with hepatitis B virus (HBV) related diseases is not well addressed. In order to prov...

Influence of renal function on the single-dose pharmacokinetics of besifovir, a novel a...
https://doi.org/10.1002/jcph.1945
Journal of Clinical Pharmacology; Hwang JG, Kim YK et. al.

Jul 31st, 2021 - Per the well-known resistance of hepatitis B virus (HBV) to nucleos(t)ide analogs, alternative treatment options with higher resistance barriers have been approved for use in both treatment-naïve and lamivudine-resistant HBV infections. This phase...

see more →

Guidelines  4 results

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS B VIRUS.
https://doi.org/10.1016/j.clinre.2021.101773
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.

Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: A...
https://doi.org/10.1200/JCO.20.01757
Journal of Clinical Oncology : Official Journal of the Am... Hwang JP, Feld JJ et. al.

Jul 28th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management. All patients anticipating systemic anticancer therapy should be tested for HBV by 3 tests-hepatitis B surface an...

Management of hepatitis B virus infection, updated Swedish guidelines.
https://doi.org/10.1080/23744235.2019.1675903
Infectious Diseases (London, England); Westin J, Aleman S et. al.

Oct 16th, 2019 - Despite access to effective antiviral drugs and vaccines, hepatitis B virus (HBV) infection remains a major health issue worldwide. HBV is highly infectious and may cause chronic infection, progressive liver damage, hepatocellular cancer (HCC) and...

Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837403
MMWR. Recommendations and Reports : Morbidity and Mortali... Schillie S, Vellozzi C et. al.

Jun 26th, 2018 - HEPATITIS B VIRUS (HBV) IS TRANSMITTED VIA BLOOD OR SEXUAL CONTACT. PERSONS WITH CHRONIC HBV INFECTION ARE AT INCREASED RISK FOR CIRRHOSIS AND LIVER CANCER AND REQUIRE MEDICAL CARE. THIS REPORT UPDATES AND SUMMARIZES PREVIOUSLY PUBLISHED RECOMMEND...

see more →

Drugs  13 results see all →

Clinicaltrials.gov  63 results

Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy
https://clinicaltrials.gov/ct2/show/NCT02582333

Mar 11th, 2020 - Background: Taiwan is one of the area with the highest prevalence of chronic hepatitis B (CHB), and many patients die of hepatitis B virus (HBV)-related cirrhosis or liver cancer that have been the leading causes of death in Taiwan for many years....

Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection
https://clinicaltrials.gov/ct2/show/NCT01368497

Mar 11th, 2020 - This single arm treatment study was conducted by the pediatric centers within the National Institute of Diabetes Digestive and Kidney Diseases (NIDDK)-sponsored Hepatitis B Research Network (HBRN). Children age 3-<18 years with immunotolerant chro...

Hepatitis B Research Network Pediatric Cohort Study (HBRN)
https://clinicaltrials.gov/ct2/show/NCT01263600

Jan 6th, 2020 - •Primary Aim: o To describe participants 6 months to <18 years of age with hepatitis B virus (HBV) infection in a prospective cohort in the United States (US) and Canada and identify predictors of disease activation and progression Secondary Aims:...

Hepatitis B Research Network Adult Cohort Study
https://clinicaltrials.gov/ct2/show/NCT01263587

Jan 6th, 2020 - Aims Primary Aim: o To describe participants with hepatitis B virus (HBV) infection in a prospective cohort in the United States (US) and Canada and identify predictors of disease activation and progression Secondary Aims: To describe clinical, vi...

A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B
https://clinicaltrials.gov/ct2/show/NCT03258710

Jan 2nd, 2020 - Tenofovir Disoproxil Fumarate is a nucleos(t)ide analogue that inhibits Hepatitis B Virus (HBV) growth, and is marketed in Japan with an indication for inhibition of HBV growth in subjects with chronic hepatitis B associated with HBV growth and ab...

see more →

News  184 results

New Antiviral Drug Promising Against HBV
https://www.medscape.com/viewarticle/955063

Jul 21st, 2021 - NEW YORK (Reuters Health) - RO7049389, a hepatitis B virus (HBV) core protein allosteric modulator, appears safe and shows antiviral action in patients with chronic HBV infection, according to a small company-funded study. "These results provide p...

Tri-antigenic Vaccine Prevents HBV Infection in Adults
https://www.medscape.com/viewarticle/952116

Jun 1st, 2021 - NEW YORK (Reuters Health) - A tri-antigenic hepatitis B vaccine (TAV) effectively prevented hepatitis B virus (HBV) infection in adults, was somewhat more effective than a mono-antigenic vaccine (MAV) comparator, but had higher side effect rates i...

Treatment Paradigm for Chronic HBV in Flux
https://www.medscape.com/viewarticle/948611

Apr 2nd, 2021 - These days deciding when to stop targeted treatment for chronic hepatitis B is a bigger challenge than knowing when to start, Norah A. Terrault, MD, MPH, observed at the Gastroenterology Updates, IBD, Liver Disease Conference. That's because the t...

USPSTF Reaffirms Advice on HBV Screening in High-Risk Individuals
https://www.medscape.com/viewarticle/942681

Dec 16th, 2020 - NEW YORK (Reuters Health) - The U.S. Preventive Services Task Force (USPSTF) continues to recommend screening for hepatitis B virus (HBV) in nonpregnant adolescents and adults at increased risk for HBV infection, concluding with "moderate certaint...

Serum Hep B Virus RNA Levels Useful When Deciding When to Stop Treatment
https://www.medscape.com/viewarticle/936294

Aug 26th, 2020 - NEW YORK (Reuters Health) - Patients with chronic hepatitis B who have undetectable serum hepatitis B virus (HBV) RNA can safely undergo cessation of entecavir antiviral treatment, according to a new study. "Serum HBV RNA reflects an important int...

see more →

Patient Education  1 results see all →